In Massachusetts, researchers found a way to help prevent fibrosis, or scar tissue from developing around medical implant devices. While biomaterial devices have been increasingly replacing metal ones in order to offer a more natural, less rejected type of material for patients’ bodies, biomaterial implants still face fibrosis issues which can impact how well the implant works. But researchers now can fight back against the scar tissue issue by blocking the molecule, CSF1, which signals to macrophages in the body to start building the scar tissue. Once blocked, the body doesn’t create the scar tissue, but interestingly, still allows the body to heal wounds and carry out other important functions. While they tested it on three different biomaterials, researchers believe it will work on any biomaterial and devices such as pacemakers and glucose sensors for diabetes patients.
Latest article
Mercedes-Benz taps Modern Meadow for 80% plant-based leather
In Germany, luxury car manufacturer Mercedes-Benz has partnered with New Jersey biodesign firm Moden Meadow to develop a next-generation leather alternative for its CONCEPT...
Bioluminescent dress from van Herpen portends era of living couture
In France, Dutch fashion designer Iris van Herpen has unveiled a dress embedded with 125 million bioluminescent algae at Paris Haute Couture Week 2025....
Stella McCartney’s latest sneaker can be composted, smells of cinnamon
In London, sustainable fashion pioneer Stella McCartney has unveiled a new version of its S-Wave sneakers, featuring soles made entirely from BioCir Flex, a...